Lyra Therapeutics, Inc.

NASDAQ:LYRA

0.265 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -62.68-55.278-43.513-22.127-16.306-6.029
Depreciation & Amortization 0.2781.0671.0010.0950.0270.082
Deferred Income Tax -0.450-2.422000
Stock Based Compensation 5.8875.4472.771.8130.2440.406
Change In Working Capital -4.8854.55513.922-0.8792.1140.079
Accounts Receivables 000000.164
Inventory 000000
Accounts Payables 0.45-2.4112.350.345-0.2050.134
Other Working Capital -5.3356.96611.572-1.2242.319-0.055
Other Non Cash Items -1.4540.8242.422-0.0450.167-1.178
Operating Cash Flow -63.304-43.385-25.82-21.143-13.754-6.64
Investing Activities:
Investments In Property Plant And Equipment -1.047-0.164-3.385-1.775-0.211-0.037
Acquisitions Net 000000
Purchases Of Investments -122.423-64.8420000
Sales Maturities Of Investments 110.88600000
Other Investing Activites -0-64.8420000
Investing Cash Flow -12.584-65.006-3.385-1.775-0.211-0.037
Financing Activities:
Debt Repayment 00000-0.5
Common Stock Issued 65.691100.4950.60459.8920.1110.012
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -3.654-4.238-0.24527.811-0.22629.213
Financing Cash Flow 65.69196.2570.35987.703-0.11529.213
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -10.197-12.134-28.84664.785-14.0822.536
Cash At End Of Period 22.35333.94246.07674.92210.13724.217